Month: February 2024

(In United States dollars, except where noted otherwise) TORONTO, Feb. 20, 2024 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX: FM) today reports results for the three months ended December 31, 2023 (“Q4 2023” or the “fourth quarter”) of a net loss attributable to shareholders of the Company of $1,447 million ($2.09 loss per share) and an adjusted loss1 of $259 million ($0.37 adjusted loss per share2). For the year ended December 31, 2023, the Company reported a net loss attributable to shareholders of the Company of $954 million ($1.38 basic loss per share) and adjusted earnings1 of $261 million ($0.38 adjusted earnings per share2). “2023 closed with the Company facing one of its biggest challenges in recent history. However, I am confident in the resilience of First Quantum...

HOUSTON, Feb. 20, 2024 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE: AROC) (“Archrock”) today reported results for the fourth quarter and full year 2023 and provided 2024 guidance. Fourth Quarter and Full Year 2023 HighlightsRevenue for the fourth quarter of 2023 was $259.6 million compared to $218.9 million in the fourth quarter of 2022. Revenue for 2023 was $990.3 million compared to $845.6 million in 2022. Net income for the fourth quarter of 2023 was $33.0 million compared to $10.5 million in the fourth quarter of 2022. Net income for 2023 was $105.0 million compared to $44.3 million in 2022. Adjusted EBITDA (a non-GAAP measure defined below) for the fourth quarter of 2023 was $120.3 million compared to $89.0 million in the fourth quarter of 2022. Adjusted EBITDA for 2023 was $450.4 million compared to $363.3 million in 2022. Leverage...

Reported fourth quarter 2023 revenue from continuing operations1 of $58.1M with more than 68% year-over-year growth of exome and genome test revenue Expanded fourth quarter 2023 adjusted gross margins2 from continuing operations to 56% Narrowed fourth quarter 2023 adjusted net loss2 to $17.8M and delivered 51% year-over-year cash burn reduction Issued guidance to deliver between $220M and $230M in FY 2024 revenue and reiterate path to profitability in 2025 GeneDx to host conference call today at 4:30 p.m. ET STAMFORD, Conn., Feb. 20, 2024 (GLOBE NEWSWIRE) — GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today reported its financial results for the fourth quarter and full year of 2023. “Our strong fourth quarter results were a product of our relentless...

OWINGS MILLS, Md., Feb. 20, 2024 (GLOBE NEWSWIRE) — Universal Security Instruments, Inc. (NYSE AMEX: UUU) today announced results for its fiscal third quarter and nine months ended December 31, 2023. For the three months ended December 31, 2023, sales decreased 19.2% to $4,654,978 compared to sales of $5,758,661 for the same period last year. The Company reported net income of $102,176, or $0.04 per basic and diluted share, compared to net income of $341,312 or $0.15 per basic and diluted share for the same period last year. For the nine months ended December 31, 2023, sales decreased 7.3% to $15,071,204 versus $16,251,106 for the same period last year. The Company reported net income of $80,881, or $0.03 per basic and diluted share, compared to net income of $435,776 or $0.19, per basic and diluted share for the corresponding...

AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023:Worldwide net sales were $616.5 million, an increase of 124.6%, or 123.8% on a constant currency basis GAAP net income for the quarter was $15.0 million GAAP diluted earnings per share (“EPS”) was $0.11 and non-GAAP diluted EPS was $0.60 Non-GAAP adjusted EBITDA was $170.0 million, or 27.6% of net salesFull Year 2023:Worldwide net sales were $1,568.5 million, an increase of 53.3% on an actual and constant currency basis GAAP net income for the year was $122.9 million GAAP diluted EPS was $1.07 and non-GAAP diluted EPS was $2.32 Non-GAAP adjusted EBITDA was $464.1 million, or 29.6% of...

La-Z-Boy Reports Fiscal 2024 Third Quarter ResultsConsolidated delivered sales of $500 millionUp 5% versus our most recent pre-pandemic third quarter Down 13% versus year ago periodResults impacted by winter weather events in January Gross margin expansion on GAAP and Non-GAAP basis, across all segments GAAP diluted EPS of $0.66Non-GAAP diluted EPS of $0.67Generated $48 million in operating cash flow for the quarter; $105 million year to date Acquired six independent La-Z-Boy Furniture Galleries® storesAdditional two-store acquisition planned for fourth quarterMONROE, Mich., Feb. 20, 2024 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB), a global leader in the manufacture and retail of residential furniture, today reported third quarter results for the period ended January 27, 2024. For the quarter, sales...

HAMILTON, Bermuda, Feb. 20, 2024 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT) today announced results for its fourth quarter ended December 31, 2023.Strong progress in 2023 as we deliver record underwriting profits, net services fee income and net income, while growing book value per share by 18%. Cost program completed a year in advance and we have over-delivered on our 2023 guidance on net investment income. Record ROE at 16.2% for 2023, ahead of our guidance of achieving double-digit ROE in 2024, even after excluding one-off adjustments. We now aim to deliver 12-15% ROE during the medium term. Balance sheet is stronger and of higher quality. Capital surplus increased given organic capital generation and strategic actions, debt and asset leverage reduced while reserve position remains conservative...

CAMPBELL, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the fourth quarter and year ended December 31, 2023 and provided first quarter and full year 2024 guidance. “We’re excited to report a strong finish to 2023, with Annual Contract Value and Trailing-Twelve-Month Variable Royalties of $56.1 million, above the high end of our guidance range,” said K. Charles Janac, President and CEO of Arteris. “We believe that the accelerating adoption of commercial System IP solutions across the industry’s most complex applications including Generative AI and advanced mobility is becoming clear. With 23 net new Active Customers in 2023, including several of the world’s largest...

Expects durable, efficient growth in 2024 CHICAGO, Feb. 20, 2024 (GLOBE NEWSWIRE) —  Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced financial results for its fourth quarter ended December 31, 2023. “We’re pleased to share incredibly strong fourth quarter results,” said Justyn Howard, Sprout Social’s CEO and co-founder. “We’re building an enduring software company centered on amazing products, amazing people and overdelivering for our customers every day. We delivered step change growth in current & total contract value bookings and were recently named the #1 best software product by G2, which we believe position Sprout to build on our momentum in 2024.” Fourth Quarter 2023 Financial Highlights RevenueRevenue...

Signed 8 deals in the fourth quarter and 32 in 2023 across both media and semiconductor Paid down $29 million of debt in fourth quarter and $148 million in 2023 SAN JOSE, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA) (the “Company” or “Adeia”) today announced financial results for the fourth quarter and full year ended December 31, 2023. “We made excellent progress toward our long-term goals in 2023,” said Paul E. Davis, chief executive officer of Adeia. “We closed 32 deals across multiple verticals in our media and semiconductor businesses, including with new customers in OTT, Pay-TV, social media and semiconductors. We exceeded our target patent portfolio growth rate of 10% and our new original patent filings hit a record in 2023, positioning us for future revenue growth. Our deal pipeline continues to expand...